ADVFN US – Market Content Editor
-
CrowdStrike Earns Top Customer Recognition in Gartner SIEM Report
CrowdStrike (NASDAQ:CRWD) has been named a Customers’ Choice in the 2026 Gartner Peer Insights “Voice of the Customer” report for Security Information and Event Management (SIEM), reflecting strong user feedback and high satisfaction levels. The company said it received the highest number of five-star ratings and the most verified reviews among vendors in the report,…
-
Allogene Publishes Promising ALLO-329 Data in Nature Communications
Allogene Therapeutics (NASDAQ:ALLO) said new pre-clinical data for its investigational CAR-T therapy ALLO-329 have been published in Nature Communications, highlighting a dual-targeting approach aimed at treating autoimmune diseases. ALLO-329 is an allogeneic, off-the-shelf CAR-T candidate designed to target both CD19-positive B cells and CD70-positive activated T cells, two key drivers of autoimmune conditions. The data…
-
Allied Gaming Resolves Legal Dispute and Outlines Shift Toward AI and Digital Assets
Allied Gaming & Entertainment Inc. (NASDAQ:AGAE) said it has reached a settlement with Knighted Pastures LLC, bringing all related legal matters to a close, according to a company statement. Following the resolution, the company is turning its attention to new strategic initiatives, including plans to launch its cryptocurrency, Allied Coin, in 2026, subject to regulatory…
-
La Rosa Holdings Takes Full Control of Orlando Brokerage Unit
La Rosa Holdings Corp. (NASDAQ:LRHC) announced it has acquired the remaining 49% stake in La Rosa Realty Orlando LLC, bringing the operation fully under its ownership. The Orlando-based business, which provides residential and commercial brokerage services along with agent coaching and support, generated approximately $3.3 million in revenue and more than $0.3 million in gross…
-
Lunai Bioworks Unit Signs Preliminary Deal with Geneial on Rare Disease Data Collaboration
Lunai Bioworks (NASDAQ:LNAI) said its subsidiary BioSymetrics has entered into a letter of intent with Geneial to explore a collaboration focused on rare neurological conditions. The non-binding agreement aims to transform patient-generated information into structured datasets that can be used to support drug development and improve clinical trial recruitment. The initiative targets rare diseases, which…
-
Immutep Shares Surge After FDA Grants Orphan Drug Status to Cancer Therapy
Immutep (NASDAQ:IMMP) shares jumped sharply on Wednesday after the company announced that the U.S. Food and Drug Administration had granted Orphan Drug Designation (ODD) to eftilagimod alfa. Eftilagimod alfa is being developed as a treatment for soft tissue sarcoma (STS), a rare and complex group of cancers that arise in connective tissues such as muscle,…
-
Vince Shares Climb After Q4 Earnings and Revenue Beat Expectations
Vince Holding Corp. (NASDAQ:VNCE) reported fourth-quarter results on Wednesday that came in ahead of analyst forecasts, sending its shares up nearly 5% in premarket trading. Adjusted earnings per share reached $0.18, outperforming the consensus estimate of a $0.13 loss. Revenue rose 4.7% year over year to $83.7 million, slightly above expectations of $83.1 million. On…
-
Robinhood Shares Surge as SEC Removes $25K Day-Trading Requirement
Robinhood Markets (NASDAQ:HOOD) shares jumped 6% on Wednesday, adding to a 10% gain in the previous session after the U.S. Securities and Exchange Commission approved changes to long-standing day-trading restrictions. The SEC on Tuesday cleared a broad overhaul of rules governing retail day trading, a move that has been welcomed by online brokerage platforms. Shares…
-
Morgan Stanley Shares Rise as Q1 Profit Tops Estimates on Strong Banking and Trading
Morgan Stanley (NYSE:MS) reported first-quarter results that came in ahead of Wall Street expectations, supported by elevated trading activity and solid client engagement during a period of heightened market volatility. Earnings per share reached $3.43, exceeding the consensus forecast of $3.02. Revenue climbed to $20.6 billion, beating estimates of $19.7 billion and rising 16% from…
-
Energous Shares Jump 17% on Expanded Deployments with Major Enterprise Clients
Energous Corporation (NASDAQ:WATT) shares surged 17% on Wednesday after the company announced broader deployments with Fortune 10 customers, including expansion into international markets. The wireless power solutions provider said its first Fortune 10 client is continuing to roll out infrastructure across roughly 4,700 targeted locations in the U.S., with more than 1,500 sites already completed.…